Finance

Lists
ELTX:NASDAQ
Elicio Therapeutics Inc
1,92 US$
0,00%
(0,00) 1D
2 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ELTX...
Mkt. cap
50,46 მლნ.
Avg. vol.
347,47 ათ.
Volume
1,00
52-wk high
16,00 US$
52-wk low
1,70 US$
EPS
-2,18 US$
Beta
1,32
Shares outstanding
26,28 მლნ.
No. of employees
33
Mkt. cap
50,46 მლნ.
Avg. vol.
347,47 ათ.
Volume
1,00
52-wk high
16,00 US$
52-wk low
1,70 US$
EPS
-2,18 US$
Beta
1,32
Shares outstanding
26,28 მლნ.
No. of employees
33
News stories
From web sources and news partners
About Elicio Therapeutics Inc
CEO-
Employees33
Founded2011
Headquartersბოსტონი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websiteelicio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ELTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ELTX in the last 3 months.
Highest
Current 1,92 US$
23,00 US$ (+1 097,92%)
Average
15,50 US$ (+707,29%)
Lowest
8,00 US$ (+316,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Maintained
8,00 US$
+316,7%
09/24/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
23,00 US$
+1 097,9%
08/21/2026
Boris Peaker
JonesTrading
Hold
Reiterated
-
-
08/17/2026
Kevin DeGeeter
Ladenburg Thalmann & Co.
Buy
Initiated
12,00 US$
+525%
06/18/2026
Aydin Huseynov
Ladenburg Thalmann & Co.
Buy
Initiated
20,00 US$
+941,7%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
18,00 US$
+837,5%
04/06/2026
Michael King
Rodman & Renshaw
Buy
Initiated
17,00 US$
+785,4%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,04 მლნ.
5,08 მლნ.
6,76 მლნ.
6,81 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,01 მლნ.
3,76 მლნ.
3,84 მლნ.
3,62 მლნ.
Operating expense
8,04 მლნ.
8,84 მლნ.
10,60 მლნ.
10,43 მლნ.
Total operating expenses
8,04 მლნ.
8,84 მლნ.
10,60 მლნ.
10,43 მლნ.
Operating income
-8,04 მლნ.
-8,84 მლნ.
-10,60 მლნ.
-10,43 მლნ.
Other non operating income
-1,81 მლნ.
1,26 მლნ.
-984,00 ათ.
2,48 მლნ.
EBT including unusual items
-10,08 მლნ.
-7,72 მლნ.
-11,82 მლნ.
-8,22 მლნ.
EBT excluding unusual items
-10,08 მლნ.
-7,72 მლნ.
-11,82 მლნ.
-8,22 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10,08 მლნ.
-7,72 მლნ.
-11,82 მლნ.
-8,22 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,60
-0,49
-0,65
-0,43
Interest and investment income
199,00 ათ.
199,00 ათ.
157,00 ათ.
138,00 ათ.
Interest expense
-426,00 ათ.
-337,00 ათ.
-407,00 ათ.
-410,00 ათ.
Net interest expenses
-227,00 ათ.
-138,00 ათ.
-250,00 ათ.
-272,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,00 მლნ.
-8,79 მლნ.
-10,56 მლნ.
-10,39 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები